Press Releases
AtriCure to Announce First Quarter 2022 Financial Results
April 11, 2022
MASON, Ohio --(BUSINESS WIRE)--Apr. 11, 2022-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter...
AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results
February 15, 2022
MASON, Ohio ,--(BUSINESS WIRE)--Feb. 15, 2022-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2021 and full year 2021...
AtriCure Publishes Inaugural ESG Report
February 08, 2022
MASON, Ohio --(BUSINESS WIRE)--Feb. 8, 2022-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today published its inaugural Environmental, Social and...
AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
February 01, 2022
MASON, Ohio --(BUSINESS WIRE)--Feb. 1, 2022-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 11 th Annual SVB Leerink Global...
AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results
January 25, 2022
MASON, Ohio --(BUSINESS WIRE)--Jan. 25, 2022-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth...
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022
January 10, 2022
MASON, Ohio --(BUSINESS WIRE)--Jan. 10, 2022-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced preliminary financial results for the fourth...
AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
December 20, 2021
MASON, Ohio --(BUSINESS WIRE)--Dec. 20, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming 40 th Annual J.P....
AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
November 12, 2021
MASON, Ohio --(BUSINESS WIRE)--Nov. 12, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming Piper Sandler 33 rd Annual...
AtriCure Reports Third Quarter 2021 Financial Results
November 03, 2021
MASON, Ohio --(BUSINESS WIRE)--Nov. 3, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced third quarter 2021 financial results. “Our results were driven by strong growth across key...
AtriCure to Announce Third Quarter 2021 Financial Results
October 05, 2021
MASON, Ohio --(BUSINESS WIRE)--Oct. 5, 2021-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release third quarter 2021 financial results on Wednesday, November 3, 2021 ....